WELCOME TO MEDSHADOW. WE'VE UPDATED OUR LOOK!

Groups Ask FDA to Pull Ultra-High-Dose Opioids From Market

Several medical and health organizations are calling on the FDA to remove ultra-high-dosage (UHD) opioid painkillers from the market since the risks of the potent meds, such as abuse and overdose, outweigh their benefits.

The Centers for Disease Control and Prevention(CDC) has recommended that patients consume no more than 90 morphine milligram equivalents (MME) of a prescription opioid every day. Groups such as Physicians for Responsible Opioid Prescribing, the National Safety Council, FED UP! Coalition to End Opioid Prescribingand the American College of Medical Toxicologysay that UHD opioids, as prescribed, often exceed 90 MME per day.

Their Citizen Petition(pdf) gives several examples of the opioids that should be withdrawn. An 80mg tablet of OxyContin (oxycodone) extended-release (ER) is often given twice daily, an amount equivalent to 240 MME a day. Oxycodone 30mg tablets in immediate-release (IR) formulation are usually prescribed to a patient to take 4 times a day, which is equivalent to 180 MME.

The document also lists other opioids that are available in UHD formulations that should be removed. They include hydromorphone, morphine, oxymorphone, hydrocodone, methadone and fentanyl.

The petition also cites some sobering statistics to support its arguments. In 2015, an estimated 1.5 million Americans misused prescription these drugs. The same year, 969,000 young people between the ages of 12 to 17 and 3 million adults aged 18 to 25 used opioids for recreational use.

The petition also states that a person who is taking an UHD opioid for pain could overdose by accidentally taking an extra dose or deliberately taking an extra pill if they don’t find relief with the first dose. Data from a CDC review found that the higher the opioid dose, the greater the chance of an overdose.

“High dose of these abuse drugs are associated with increased risk for motor vehicle accidents, fractures from falls, immune suppression, and opioid associated androgen deficiency which can cause reduced libido, erectile dysfunction, fatigue, depression, decreased muscle mass, weight gain, osteoporosis and infertility,” the organizations say.

They conclude that, given a new FDA framework for evaluating the benefit and risks that takes into account opioid misuse, “the need for removal of UHDs becomes even more clear.”

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Was This Article Helpful?

Show Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x